India must focus on genomic surveillance of Mpox virus to curb spread: Experts
New Delhi, Aug 19 (IANS) India must focus on genomic surveillance to understand the Mpox virus, and develop ways to curb its spread, said experts on Monday. The deadly Mpox virus is seeing another outbreak, especially in Africa, where so far about 14 countries have been, with 4 nations reporting the infection for the first
New Delhi, Aug 19 (IANS) India must focus on genomic surveillance to understand the Mpox virus, and develop ways to curb its spread, said experts on Monday.
The deadly Mpox virus is seeing another outbreak, especially in Africa, where so far about 14 countries have been, with 4 nations reporting the infection for the first time. The number of cases reported so far this year has exceeded last year’s total, with more than 15,600 cases and 537 deaths.
This prompted the Africa CDC and the World Health Organization (WHO) to declare the disease as a global health emergency.
In 2022 Mpox had a global outbreak with many countries, including India, being affected. Since then, the WHO has reported 99,176 cases and 208 deaths due to Mpox from 116 countries. India detected a total of 30 cases, with the last case in March 2024.
“We need to focus on genomic surveillance of the virus to understand the genetic epidemiology, the spread, and the evolution of the virus,” noted biologist Vinod Scaria told IANS.
He also called for developing “good diagnostics for faster diagnosis and better care of affected individuals”.
Mpox was first identified in monkeys in research laboratories in the 1950s, and it was not until 1970 that the first human case was discovered.
It has been mostly localised and endemic in the Congo Basin, as well as in West Africa. There have been two types, clade one, which is mostly in the Congo region, and clade two, which is seen primarily in West Africa.
Dr Anurag Agarwal, Dean, BioSciences and Health Research, Trivedi School of Biosciences, Ashoka University, told IANS that the 2022 outbreak was driven by clade 2, which is a less virulent, and the infections were primarily seen in men who had sex with other men.
“The current outbreak that we are seeing in Africa is clade Ib. Clade Ib has a higher mortality and more severe disease than Clade II. And also, while clade one typically does not have human-to-human transmission, here we are seeing infection and deaths in a large number of children, which is making people worry,” he added.
The latest outbreak of monkeypox has not only “played beyond the borders” but also reported “deaths in young children, where you don’t expect any sexual transmission”.
“That is the reason why the WHO has given a global warning for international concern”.
So far, outside of Africa, the infection, driven by the Clade 1b strain of the monkeypox virus, has been detected only in Sweden. Separately, Pakistan (3) and the Philippines (1) have reported lab-confirmed cases of Mpox. However, the variant remains unknown. The US’s California has also reported detecting Mpox in wastewater surveillance.
“The fear is that this virus could evolve. The fear is that this virus could develop respiratory transmission and become deadly. The best way to prevent that is to reduce the number of infections, to keep it within the geography it currently is, and slowly wipe it out,” Dr. Agarwal said, noting the need to build more diagnostics, vaccines, and genomic surveillance as during the Covid-19 pandemic.
–IANS
rvt/
ପୋଖରୀରେ ବୁଡ଼ି ଦୁଇ ନାବାଳିକା ମୃତ
Next ArticleLightning strikes kill 15 in Odisha in two days; CM announces ex-gratia
Related Articles
New AI tool to revolutionise personalised cancer treatment

स्वास्थ्य व लाइफस्टाइलNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

स्वास्थ्य व लाइफस्टाइलCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

स्वास्थ्य व लाइफस्टाइलGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
